Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousKidney TransplantationLiver TransplantationTransplantation ConditioningBone Marrow TransplantationGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationGraft SurvivalHeart TransplantationCell TransplantationTissue DonorsLung TransplantationGraft RejectionImmunosuppressive AgentsHematologic NeoplasmsTreatment OutcomeTransplantation ChimeraTransplantationCord Blood Stem Cell TransplantationTransplantation ImmunologyHistocompatibility TestingRetrospective StudiesIslets of Langerhans TransplantationTransplantsOrgan TransplantationMyeloablative AgonistsRecurrenceWhole-Body IrradiationLiving DonorsHistocompatibilityTime FactorsImmunosuppressionBusulfanTransplantation, IsogeneicMesenchymal Stem Cell TransplantationTissue and Organ ProcurementPancreas TransplantationCyclosporineSurvival AnalysisSurvival RateCombined Modality TherapyFollow-Up StudiesFetal Tissue TransplantationMultiple MyelomaTacrolimusPostoperative ComplicationsTransplantation ToleranceLeukemiaRemission InductionMelphalanHeart-Lung TransplantationTransplantation, HeterotopicCytomegalovirus InfectionsHLA AntigensGraft vs Leukemia EffectLiver FailureDisease-Free SurvivalVidarabineWaiting ListsAntilymphocyte SerumCyclophosphamideGraft vs Tumor EffectChimerismLeukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseRisk FactorsSiblingsAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell MobilizationAcute DiseaseMycophenolic AcidSalvage TherapyBrain Tissue TransplantationHematologic DiseasesUnrelated DonorsLymphocyte TransfusionImmunocompromised HostPrognosisCadaverLymphoma, Non-HodgkinMyelodysplastic SyndromesAnemia, AplasticTransplantation, HeterologousAntigens, CD34Precursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionDonor SelectionBronchiolitis ObliteransSkin TransplantationProspective StudiesInfectionHematopoietic Stem CellsTissue TransplantationKidney Failure, ChronicLiver DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphoproliferative Disorders